Home NDC 36000-065 FUROSEMIDE
Product NDC 36000-065
11-digit product format 360000065
Labeler code 36000
Product ID 36000-065_b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name furosemide
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Baxter Healthcare Corporation
Application ANDA202747
Marketing category ANDA
Marketing start 2014-02-06
Substance FUROSEMIDE
Active strength 10 mg/mL
Pharmacologic classes Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202747-001 FUROSEMIDE FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A202747-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A202747-001 FUROSEMIDE 10MG/ML INJECTABLE / INJECTION AP RS 2014-01-27 3a93d1ddd44b…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base FUROSEMIDE
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FUROSEMIDE 10 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7LXU5N7ZO5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1719286 Internal RxNorm lookup 1719290 Internal RxNorm lookup 1719291 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 36000-065-05 FUROSEMIDE 10 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 10 23 36000-065-05 FUROSEMIDE 5 in 1 BOX INJECTION, SOLUTION 5 23
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8 WATER INACTIVE INGREDIENT 059QF0KO0R FUROSEMIDE INJECTION, SOLUTION [CLARIS LIFESCIENCES, INC] 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 36000-065 FUROSEMIDE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] 21 Current NDC, Legacy NDC, 2 package rows 20240921_c71371a7-75c5-45b8-b762-8d782d4c71bc.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join FUROSEMIDE FUROSEMIDE Civica, Inc. 7ecaa5af-d186-4380-b105-e7e528f75cc7 2025-11-12 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 202747 application number: ANDA202747 FUROSEMIDE FUROSEMIDE Baxter Healthcare Corporation c71371a7-75c5-45b8-b762-8d782d4c71bc 2025-06-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 202747 application number: ANDA202747 ndc (product): 36000-065 FUROSEMIDE FUROSEMIDE Medical Purchasing Solutions, LLC 6a2235e8-d488-2d43-e053-2991aa0aa485 2023-05-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 202747 application number: ANDA202747 FUROSEMIDE FUROSEMIDE Medical Purchasing Solutions, LLC 6947af02-f50b-7f9c-e053-2a91aa0a45cd 2023-05-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 202747 application number: ANDA202747
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 36000-065-05 36000006505 5 VIAL, SINGLE-DOSE in 1 BOX (36000-065-05) / 10 mL in 1 VIAL, SINGLE-DOSE 2014-02-06 0000-00-00 No No Current